News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Tomovircona, a Novel RNAi-Based Virucide by Silicon Gene Technologies (Shanghai) Co., Ltd., Receives ISO approval

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy’s Laboratories

    adminFebruary 17, 202201.9k views

    Summary : Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy’s Laboratories to acquire two brands — Combihale and Daffy. While Combihale…

    Read more

    Glenmark inks pact to commercialise AstraZeneca’s asthma drug in Colombian market

    adminFebruary 16, 202201.7k views

    Summary : Glenmark Pharmaceuticals on Monday said its subsidiary has inked a pact to commercialise AstraZeneca’s asthma drug Pulmicort Respules in the…

    Read more

    Zydus Pharmaceuticals (USA) Inc gets final US FDA approval to market Roflumilast tablets

    adminFebruary 16, 202202.7k views

    Summary: Zydus, being one of the first applicants for Roflumilast Tablets, 500 mcg, is eligible for 180 days of shared generic drug…

    Read more

    Macleods Pharma files papers for IPO, likely to be one of the biggest in sector

    adminFebruary 16, 202202.1k views

    Summary : The Rs 6,480-crore IPO of Gland Pharma, which was launched in November 2020, holds the record for the biggest ever…

    Read more

    Antibodies improve in quality for months after COVID-19 vaccination

    adminFebruary 16, 202201.5k views

    Synopsis: For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted…

    Read more

    Not so NICE: cancer patients miss out on innovative new treatments

    adminFebruary 16, 202201.5k views

    Summary : Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes National Institute for Health…

    Read more

    Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy

    adminFebruary 16, 202201.8k views

    Summary : SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy Around 55,000 people in…

    Read more

    Two cases of ‘eye bleeding’ Lassa fever found in UK

    adminFebruary 16, 202203.2k views

    Synopsis : Rare viral haemorrhagic disease similar to Ebola surface in the East of England. Two people in the UK have been…

    Read more

    AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Third- and Fourth-Line Renal Cell Carcinoma

    adminFebruary 15, 202201.9k views

    Summary- Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience long-term PFS compared to Nexavar® (sorafenib)…

    Read more

    Lilly, Roche Push Back Against CMS Draft Guidance on Aduhelm

    adminFebruary 15, 202201.8k views

    Summary The U.S. Centers for Medicare & Medicaid Services (CMS) just completed the open comment period for their draft national coverage decision…

    Read more

    Posts navigation

    1 … 43 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top